IBDEI2LO ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,43643,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43643,1,3,0)
 ;;=3^Athscl Natv Art of Lt Leg w/ Ulceration of Unspec Site
 ;;^UTILITY(U,$J,358.3,43643,1,4,0)
 ;;=4^I70.249
 ;;^UTILITY(U,$J,358.3,43643,2)
 ;;=^5007601
 ;;^UTILITY(U,$J,358.3,43644,0)
 ;;=I70.239^^200^2215^8
 ;;^UTILITY(U,$J,358.3,43644,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43644,1,3,0)
 ;;=3^Athscl Natv Art of Rt Leg w/ Ulcer of Unspec Site
 ;;^UTILITY(U,$J,358.3,43644,1,4,0)
 ;;=4^I70.239
 ;;^UTILITY(U,$J,358.3,43644,2)
 ;;=^5007594
 ;;^UTILITY(U,$J,358.3,43645,0)
 ;;=I70.269^^200^2215^9
 ;;^UTILITY(U,$J,358.3,43645,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43645,1,3,0)
 ;;=3^Athscl Natv Arteries of Extrm w/ Gangrene,Unspec Extremity
 ;;^UTILITY(U,$J,358.3,43645,1,4,0)
 ;;=4^I70.269
 ;;^UTILITY(U,$J,358.3,43645,2)
 ;;=^5007607
 ;;^UTILITY(U,$J,358.3,43646,0)
 ;;=I70.263^^200^2215^10
 ;;^UTILITY(U,$J,358.3,43646,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43646,1,3,0)
 ;;=3^Athscl Natv Arteries of Extrm w/ Gangrene,Bilateral Legs
 ;;^UTILITY(U,$J,358.3,43646,1,4,0)
 ;;=4^I70.263
 ;;^UTILITY(U,$J,358.3,43646,2)
 ;;=^5007605
 ;;^UTILITY(U,$J,358.3,43647,0)
 ;;=I70.262^^200^2215^11
 ;;^UTILITY(U,$J,358.3,43647,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43647,1,3,0)
 ;;=3^Athscl Natv Arteries of Extrm w/ Gangrene,Left Leg
 ;;^UTILITY(U,$J,358.3,43647,1,4,0)
 ;;=4^I70.262
 ;;^UTILITY(U,$J,358.3,43647,2)
 ;;=^5007604
 ;;^UTILITY(U,$J,358.3,43648,0)
 ;;=I70.261^^200^2215^12
 ;;^UTILITY(U,$J,358.3,43648,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43648,1,3,0)
 ;;=3^Athscl Natv Arteries of Extrm w/ Gangrene,Right Leg
 ;;^UTILITY(U,$J,358.3,43648,1,4,0)
 ;;=4^I70.261
 ;;^UTILITY(U,$J,358.3,43648,2)
 ;;=^5007603
 ;;^UTILITY(U,$J,358.3,43649,0)
 ;;=I71.2^^200^2215^20
 ;;^UTILITY(U,$J,358.3,43649,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43649,1,3,0)
 ;;=3^Thoracic Aortic Aneurysm w/o Rupture
 ;;^UTILITY(U,$J,358.3,43649,1,4,0)
 ;;=4^I71.2
 ;;^UTILITY(U,$J,358.3,43649,2)
 ;;=^5007787
 ;;^UTILITY(U,$J,358.3,43650,0)
 ;;=I71.4^^200^2215^1
 ;;^UTILITY(U,$J,358.3,43650,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43650,1,3,0)
 ;;=3^Abdominal Aortic Aneurysm w/o Rupture
 ;;^UTILITY(U,$J,358.3,43650,1,4,0)
 ;;=4^I71.4
 ;;^UTILITY(U,$J,358.3,43650,2)
 ;;=^5007789
 ;;^UTILITY(U,$J,358.3,43651,0)
 ;;=I73.9^^200^2215^19
 ;;^UTILITY(U,$J,358.3,43651,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43651,1,3,0)
 ;;=3^Peripheral Vascular Disease,Unspec
 ;;^UTILITY(U,$J,358.3,43651,1,4,0)
 ;;=4^I73.9
 ;;^UTILITY(U,$J,358.3,43651,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,43652,0)
 ;;=I82.891^^200^2215^14
 ;;^UTILITY(U,$J,358.3,43652,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43652,1,3,0)
 ;;=3^Embolism/Thrombosis Oth Spec Veins,Chronic
 ;;^UTILITY(U,$J,358.3,43652,1,4,0)
 ;;=4^I82.891
 ;;^UTILITY(U,$J,358.3,43652,2)
 ;;=^5007939
 ;;^UTILITY(U,$J,358.3,43653,0)
 ;;=I82.890^^200^2215^13
 ;;^UTILITY(U,$J,358.3,43653,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43653,1,3,0)
 ;;=3^Embolism/Thrombosis Oth Spec Veins,Acute
 ;;^UTILITY(U,$J,358.3,43653,1,4,0)
 ;;=4^I82.890
 ;;^UTILITY(U,$J,358.3,43653,2)
 ;;=^5007938
 ;;^UTILITY(U,$J,358.3,43654,0)
 ;;=E78.0^^200^2216^12
 ;;^UTILITY(U,$J,358.3,43654,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43654,1,3,0)
 ;;=3^Pure Hypercholesterolemia
 ;;^UTILITY(U,$J,358.3,43654,1,4,0)
 ;;=4^E78.0
 ;;^UTILITY(U,$J,358.3,43654,2)
 ;;=^5002966
 ;;^UTILITY(U,$J,358.3,43655,0)
 ;;=E78.1^^200^2216^13
 ;;^UTILITY(U,$J,358.3,43655,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43655,1,3,0)
 ;;=3^Pure Hyperglyceridemia
